These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37672605)

  • 1. A Randomized Three-Arm Double-Blind Placebo-Controlled Study of Homeopathic Treatment of Children and Youth with Attention-Deficit/Hyperactivity Disorder.
    Brulé D; Landau-Halpern B; Nastase V; Zemans M; Mitsakakis N; Boon H
    J Integr Complement Med; 2024 Mar; 30(3):279-287. PubMed ID: 37672605
    [No Abstract]   [Full Text] [Related]  

  • 2. Homeopathy for attention-deficit/hyperactivity disorder: a pilot randomized-controlled trial.
    Jacobs J; Williams AL; Girard C; Njike VY; Katz D
    J Altern Complement Med; 2005 Oct; 11(5):799-806. PubMed ID: 16296913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial.
    Frei H; Everts R; von Ammon K; Kaufmann F; Walther D; Hsu-Schmitz SF; Collenberg M; Fuhrer K; Hassink R; Steinlin M; Thurneysen A
    Eur J Pediatr; 2005 Dec; 164(12):758-67. PubMed ID: 16047154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial.
    Frei H; Everts R; von Ammon K; Kaufmann F; Walther D; Schmitz SF; Collenberg M; Steinlin M; Lim C; Thurneysen A
    Homeopathy; 2007 Jan; 96(1):35-41. PubMed ID: 17227746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeopathy for treatment of irritable bowel syndrome.
    Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting.
    Frei H; Thurneysen A
    Br Homeopath J; 2001 Oct; 90(4):183-8. PubMed ID: 11680802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.
    Brien S; Lachance L; Prescott P; McDermott C; Lewith G
    Rheumatology (Oxford); 2011 Jun; 50(6):1070-82. PubMed ID: 21076131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative consecutive case series of 20 children with a diagnosis of ADHD receiving homeopathic treatment, compared with 10 children receiving usual care.
    Fibert P; Relton C; Heirs M; Bowden D
    Homeopathy; 2016 May; 105(2):194-201. PubMed ID: 27211327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label pilot study of homeopathic treatment of attention deficit hyperactivity disorder in children and youth.
    Brulé D; Sule L; Landau-Halpern B; Nastase V; Jain U; Vohra S; Boon H
    Forsch Komplementmed; 2014; 21(5):302-9. PubMed ID: 25427521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeopathy for treatment of irritable bowel syndrome.
    Peckham EJ; Nelson EA; Greenhalgh J; Cooper K; Roberts ER; Agrawal A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009710. PubMed ID: 24222383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP): study protocol for a randomized, double-dummy, double-blind, placebo-controlled trial.
    Macías-Cortés Edel C; Aguilar-Faisal L; Asbun-Bojalil J
    Trials; 2013 Apr; 14():105. PubMed ID: 23782520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
    Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP
    Encephale; 2005; 31(3):337-48. PubMed ID: 16142049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of attention deficit hyperactivity disorder in children: results of a multicenter, randomized, double-blind, placebo-controlled clinical trial].
    Zavadenko NN; Makushkin EV; Gaynetdinova DD; Kolokolov OV; Malinina EV; Antipenko EA; Sagutdinova ES; Khaletskaya OV; Dmitriev AV; Maslova NN; Mashin VV; Panteleeva MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):62-68. PubMed ID: 36440779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
    Stein MA; Sikirica V; Weiss MD; Robertson B; Lyne A; Newcorn JH
    CNS Drugs; 2015 Nov; 29(11):953-62. PubMed ID: 26547425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
    Kelsey DK; Sumner CR; Casat CD; Coury DL; Quintana H; Saylor KE; Sutton VK; Gonzales J; Malcolm SK; Schuh KJ; Allen AJ
    Pediatrics; 2004 Jul; 114(1):e1-8. PubMed ID: 15231966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study).
    Adler UC; Adler MS; Padula AEM; Hotta LM; de Toledo Cesar A; Diniz JNM; de Freitas Santos H; Martinez EZ
    J Integr Med; 2022 May; 20(3):221-229. PubMed ID: 35339397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.
    Weber W; Vander Stoep A; McCarty RL; Weiss NS; Biederman J; McClellan J
    JAMA; 2008 Jun; 299(22):2633-41. PubMed ID: 18544723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.